These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1317595)

  • 1. Cellular receptor for Epstein-Barr virus.
    McClure JE
    Prog Med Virol; 1992; 39():116-38. PubMed ID: 1317595
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the B-lymphocyte Epstein-Barr virus/C3d receptor.
    Nemerow GR; Moore MD; Cooper NR
    Adv Cancer Res; 1990; 54():273-300. PubMed ID: 2136962
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement receptors.
    Holers VM
    Year Immunol; 1989; 4():231-40. PubMed ID: 2538973
    [No Abstract]   [Full Text] [Related]  

  • 7. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).
    Fingeroth JD; Clabby ML; Strominger JD
    J Virol; 1988 Apr; 62(4):1442-7. PubMed ID: 2831405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).
    Fingeroth JD
    J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT; Ahearn JM
    Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
    Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH
    J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10.
    Zdanov A; Schalk-Hihi C; Menon S; Moore KW; Wlodawer A
    J Mol Biol; 1997 May; 268(2):460-7. PubMed ID: 9159483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).
    Fearon DT; Klickstein LB; Wong WW; Wilson JG; Moore FD; Weis JJ; Weis JH; Jack RM; Carter RH; Ahearn JA
    Prog Clin Biol Res; 1989; 297():211-20. PubMed ID: 2531419
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.
    Levine J; Pflugfelder SC; Yen M; Crouse CA; Atherton SS
    Reg Immunol; 1990-1991; 3(4):164-70. PubMed ID: 1966579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.
    Nemerow GR; Mullen JJ; Dickson PW; Cooper NR
    J Virol; 1990 Mar; 64(3):1348-52. PubMed ID: 2154612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.
    Moore MD; Cooper NR; Tack BF; Nemerow GR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9194-8. PubMed ID: 2827171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
    Fujisaku A; Harley JB; Frank MB; Gruner BA; Frazier B; Holers VM
    J Biol Chem; 1989 Feb; 264(4):2118-25. PubMed ID: 2563370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.